Celia R Berkers1, 2, 6, Martijn Verdoes1, 5, 6, Eben Lichtman1, Edda Fiebiger1, Benedikt M Kessler1, Kenneth C Anderson3, Hidde L Ploegh1, Huib Ovaa1, 2
& Paul J Galardy1, 41
Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.
2
Division of Cellular Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
3
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
4
Program in Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA.
5
Present address: Leiden Institute of Chemistry, Leiden University, P.O. Box 9502, 2300 RA Leiden, the Netherlands.
6
These authors contributed equally to this work.
Correspondence should be addressed to Huib Ovaa h.ovaa@nki.nl
